Cannabis Orchards to Partner with NIH to Study Minor Cannabinoids for Epilepsy Treatment
Biotechnology December 13, 2022
Ryan Allway December 13th, 2022 News, Top News Cannabis Orchards Announces Agreement with National Institute Health to Screen Minor Cannabinoids for Epilepsy Treatment Ottawa, Canada (December 13 2022) – Cannabis Orchards Inc., a biotechnology company focused on the research, development and commercialization of minor cannabinoids and innovative industrial... Read more
22nd Century Group (Nasdaq: XXII) to Announce Second Quarter 2022 Results on August 9, 2022
Biotechnology July 27, 2022
Ryan Allway July 27th, 2022 News, Top News BUFFALO, N.Y., July 27, 2022 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, will host a live webcast on Tuesday, August... Read more
22nd Century Group (Nasdaq: XXII) Strengthens Balance Sheet to Accelerate the Expansion of VLN Launch
BiotechnologyHemp July 21, 2022
Ryan Allway July 21st, 2022 News, Top News Announces $35 Million Above Market Financing Bolsters Company’s Position with Ongoing Strategic Discussions BUFFALO, N.Y., July 21, 2022 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis,... Read more
Mydecine Files Full Patent Application Covering MYCO-006 Family of Novel Short-Acting MDMA Analogs
Biotechnology July 19, 2022
Ryan Allway July 19th, 2022 Psychedelics, Top News Company aims to increase health equity by developing more accessible treatment modalities better suited for existing healthcare infrastructure DENVER, July 19, 2022 (GLOBE NEWSWIRE) — Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology... Read more
/R E P E A T – Nova Mentis and KGK Science Form Tactical Partnership/
Biotechnology January 27, 2022
Ryan Allway January 27th, 2022 The Companies Plan to Jointly Submit a Psilocybin Clinical Trial Application to Health Canada VANCOUVER, BC, Jan. 27, 2022 /CNW/ – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for... Read more
Rapid Dose Therapeutics Strengthens Leadership Team with Addition of Rodney Butt & Appoints New Advisory Board Member
Biotechnology December 15, 2021
Ryan Allway December 15th, 2021 Additions to support immediate commercialization efforts for the Company’s COVID-19 vaccine candidate BURLINGTON, Ontario, December 15, 2021–(BUSINESS WIRE)–Rapid Dose Therapeutics Corp. (“RDT” or the “Company“) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, is pleased to announce a significant addition to... Read more
Pasithea Therapeutics Corp. Announces Pricing of a $30.4 Million Private Placement Priced at a Premium to the Market Under Nasdaq Rules
Biotechnology November 24, 2021
Ryan Allway November 24th, 2021 Psychedelics MIAMI BEACH, Fla., Nov. 24, 2021 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (Nasdaq: KTTA; KTTAW) (“Pasithea” or the “Company”), a biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders, today announced that it has... Read more
Cybin Announces Appointment of Dr. Amir Inamdar as Chief Medical Officer for European Operations and Dr. Geoff Varty as the Head of Research and Development
Biotechnology October 1, 2021
Ryan Allway October 1st, 2021 Psychedelics TORONTO, October 01, 2021–(BUSINESS WIRE)–Cybin Inc. (NEO:CYBN) (NYSE AMERICAN:CYBN) (“Cybin” or the “Company“), a biotechnology company focused on progressing psychedelic therapeutics, is pleased to announce: the addition of Dr. Amir Inamdar as its Chief Medical Officer for its European Operations, the addition of Dr.... Read more
PharmaTher Added to the North American Psychedelics Index and First Psychedelic Exchange Traded Fund
Biotechnology September 21, 2021
Ryan Allway September 21st, 2021 Psychedelics TORONTO, Sept. 21, 2021 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage psychedelics biotech company, is pleased to announce that the Company has been included to the North American Psychedelics Index, (the “Index”), which is... Read more
Willow Biosciences Announces Commercial Scale Operational Update, CBGA Production Update and Corporate Update
Biotechnology September 21, 2021
Ryan Allway September 21st, 2021 VANCOUVER, BC, Sept. 21, 2021 /PRNewswire/ – Willow Biosciences Inc. (“Willow” or the “Company“) (TSX: WLLW) (OTCQX: CANSF), a leading biotechnology company that manufactures ultra-pure, sustainably produced cannabinoids via yeast-based biosynthesis, is pleased to provide the following operational and corporate updates. Commercial Scale Operational Update In March... Read more
- 1
- 2
